论文部分内容阅读
药品的治疗特性,决定了它的平行进口不仅关系到知识产权人的利益,更关系到社会公众的利益。因此世界上很多国家虽然限制普通商品的平行进口,但是在涉及药品的平行进口方面,却政策各异。本文在通过对几个代表性国家的平行进口政策分析研究的基础上,提出我国的政策建议。
The therapeutic characteristics of drugs determine that its parallel imports are not only related to the interests of intellectual property but also to the interests of the general public. Therefore, although many countries in the world restrict the parallel imports of ordinary commodities, they have different policies concerning parallel imports involving medicines. Based on the analysis of the parallel import policies of several representative countries, this paper puts forward the policy suggestions of our country.